Literature DB >> 7678742

Release of cartilage macromolecules into the synovial fluid in patients with acute and prolonged phases of reactive arthritis.

T Saxne1, A Glennås, T K Kvien, K Melby, D Heinegård.   

Abstract

OBJECTIVE: Extensive changes in articular cartilage metabolism occur during the acute phase of reactive arthritis, as indicated by altered release of cartilage macromolecules into synovial fluid (SF) demonstrated immunochemically. Nevertheless, permanent cartilage lesions are rare in this disease. To monitor specific events during the evolution of reactive arthritis, we investigated the content of cartilage macromolecules in sequentially obtained SF samples from 22 patients.
METHODS: Two groups of proteoglycan epitopes, the glycosaminoglycan-rich region of aggrecan (referred to as proteoglycan) and its hyaluronan-binding region (HABr), as well as one matrix protein, cartilage oligomeric matrix protein (COMP), were quantified by immunoassay.
RESULTS: SF proteoglycan concentrations, which were initially elevated, decreased significantly with prolonged arthritis, whereas COMP levels changed less markedly and levels of HABr remained stable. There was a positive correlation between SF and serum concentrations of COMP in samples obtained during the early phase of the disease.
CONCLUSION: Cartilage involvement in reactive arthritis is transient, in contrast to findings in rheumatoid arthritis. Reactive arthritis should therefore be a suitable model for studies of repair processes in cartilage, which will facilitate understanding of the pathophysiology of cartilage involvement in arthritis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678742     DOI: 10.1002/art.1780360105

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  14 in total

1.  Bacterial arthritis in the elderly: an overview.

Authors:  P Kortekangas
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

2.  Stem cell transplantation: limits and hopes.

Authors:  K P Machold; J S Smolen
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

3.  Markers of joint destruction: principles, problems, and potential.

Authors:  S A Young-Min; T E Cawston; I D Griffiths
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

Review 4.  Nonsteroidal anti-inflammatory drugs and chondroprotection. A review of the evidence.

Authors:  P Ghosh
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

5.  Immunochemical markers of joint inflammation, skeletal damage and repair: where are we now?

Authors:  A R Poole
Journal:  Ann Rheum Dis       Date:  1994-01       Impact factor: 19.103

Review 6.  Articular cartilage and osteoarthrosis. The role of molecular markers to monitor breakdown, repair and disease.

Authors:  L S Lohmander
Journal:  J Anat       Date:  1994-06       Impact factor: 2.610

7.  Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis.

Authors:  B Mânsson; A Gülfe; P Geborek; D Heinegård; T Saxne
Journal:  Ann Rheum Dis       Date:  2001-01       Impact factor: 19.103

8.  Structure and interactions of aggrecans: statistical thermodynamic approach.

Authors:  Rikkert J Nap; Igal Szleifer
Journal:  Biophys J       Date:  2008-08-08       Impact factor: 4.033

9.  Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis.

Authors:  L S Lohmander; T Saxne; D K Heinegård
Journal:  Ann Rheum Dis       Date:  1994-01       Impact factor: 19.103

10.  Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study.

Authors:  Staffan Larsson; L Stefan Lohmander; André Struglics
Journal:  Arthritis Res Ther       Date:  2009-06-22       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.